Prestwick2_000997 | Market Exclusivity | US | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
NEW Find Prospects
- Prospector
Drugs in Dev.
News
Blog
Market Place
Login

Prestwick2_000997
US Exclusivities

PharmaCompass Sponsored Ads

Contact Supplier

Vamsi labs Fluticasone Propionate

Contact Supplier

pharmacompass-1-m-2026-01-12

PharmaCompass Sponsored Ads

Contact Supplier

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

pharmacompass-2-2026-02-09

Prestwick2_000997

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

80 API Suppliers, 31 USDMF, 30 CEP/COS, 6 JDMF, 6 EU WC, 2 KDMF, 28 NDC API, 47 Listed Suppliers, $ API Reference Price

80 API Suppliers
31 USDMF
30 CEP/COS
6 JDMF
6 EU WC
2 KDMF
28 NDC API
47 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

165 Drugs in Development

165 Drugs in Development

INTERMEDIATES

3 Intermediate Suppliers

3 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

1273 FDF Dossiers, 75 FDA Orange Book, 982 Europe, 33 Canada, 76 Australia, 53 South Africa, 54 Listed Dossiers

1273 FDF Dossiers
75 FDA Orange Book
982 Europe
33 Canada
76 Australia
53 South Africa
54 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

OINTMENT;TOPICAL - 0.005% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SPRAY, METERED;NASAL - 0.05MG/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SPRAY, METERED;NASAL - 0.137MG/SPRAY;0.05MG/SPRAY, SPRAY, METERED;NASAL - 0.05MG/SPRAY, POWDER;INHALATION - 0.05MG/INH, POWDER;INHALATION - 0.1MG/INH, POWDER;INHALATION - 0.25MG/INH, POWDER;INHALATION - 0.03MG/INH, POWDER;INHALATION - 0.055MG/INH, POWDER;INHALATION - 0.113MG/INH, POWDER;INHALATION - 0.232MG/INH, POWDER;INHALATION - 0.055MG/INH;EQ 0.014MG BASE/INH, POWDER;INHALATION - 0.113MG/INH;EQ 0.014MG BASE/INH, POWDER;INHALATION - 0.232MG/INH;EQ 0.014MG BASE/INH, POWDER;INHALATION - 0.1MG/INH;EQ 0.05MG BASE/INH, POWDER;INHALATION - 0.25MG/INH;EQ 0.05MG BASE/INH, POWDER;INHALATION - 0.5MG/INH;EQ 0.05MG BASE/INH, LOTION;TOPICAL - 0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, AEROSOL, METERED;INHALATION - 0.045MG/INH;EQ 0.021MG BASE/INH, AEROSOL, METERED;INHALATION - 0.115MG/INH;EQ 0.021MG BASE/INH, AEROSOL, METERED;INHALATION - 0.23MG/INH;EQ 0.021MG BASE/INH, AEROSOL, METERED;INHALATION - 0.044MG/INH, AEROSOL, METERED;INHALATION - 0.11MG/INH, AEROSOL, METERED;INHALATION - 0.22MG/INH

OINTMENT;TOPICAL - 0.005% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
SPRAY, METERED;NASAL - 0.05MG/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
SPRAY, METERED;NASAL - 0.137MG/SPRAY;0.05MG/SPRAY
SPRAY, METERED;NASAL - 0.05MG/SPRAY
POWDER;INHALATION - 0.05MG/INH
POWDER;INHALATION - 0.1MG/INH
POWDER;INHALATION - 0.25MG/INH
POWDER;INHALATION - 0.03MG/INH
POWDER;INHALATION - 0.055MG/INH
POWDER;INHALATION - 0.113MG/INH
POWDER;INHALATION - 0.232MG/INH
POWDER;INHALATION - 0.055MG/INH;EQ 0.014MG BASE/INH
POWDER;INHALATION - 0.113MG/INH;EQ 0.014MG BASE/INH
POWDER;INHALATION - 0.232MG/INH;EQ 0.014MG BASE/INH
POWDER;INHALATION - 0.1MG/INH;EQ 0.05MG BASE/INH
POWDER;INHALATION - 0.25MG/INH;EQ 0.05MG BASE/INH
POWDER;INHALATION - 0.5MG/INH;EQ 0.05MG BASE/INH
LOTION;TOPICAL - 0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
AEROSOL, METERED;INHALATION - 0.045MG/INH;EQ 0.021MG BASE/INH
AEROSOL, METERED;INHALATION - 0.115MG/INH;EQ 0.021MG BASE/INH
AEROSOL, METERED;INHALATION - 0.23MG/INH;EQ 0.021MG BASE/INH
AEROSOL, METERED;INHALATION - 0.044MG/INH
AEROSOL, METERED;INHALATION - 0.11MG/INH
AEROSOL, METERED;INHALATION - 0.22MG/INH

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 1 Rochem International Inc, 2 SPI Pharma, 4 Gangwal Healthcare, 6 Nanjing Well Pharmaceutical, 6 Kirsch Pharma, 10 Actylis, 3 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 11 BASF, 1 CD Formulation, 5 DFE Pharma, 2 Finar, 7 Gangwal Chemicals, 1 Gloria Interchem, 1 Ideal Cures, 1 Ingredion Pharma Solutions, 12 Kerry, 3 Keval Exports, 1 Kima Chemical, 10 Microlex e.U, 1 Nanjing Bold Chemical, 1 Nitika Pharmaceutical Specialities, 1 Pharmatrans-Sanaq, 4 Pluviaendo, 2 Prachin Chemical, 10 Roquette, 8 Seppic, 2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 9 Sigachi Industries, 2 Silverline Chemicals, 1 The Dow Chemical Company, 1 Valens Pharmachem, 2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

28 Fillers, Diluents & Binders, 22 Thickeners and Stabilizers, 21 Solubilizers, 19 Topical, 19 Parenteral, 17 Direct Compression, 15 Granulation, 14 Disintegrants & Superdisintegrants, 10 Emulsifying Agents, 10 Co-Processed Excipients, 8 Controlled & Modified Release, 7 Film Formers & Plasticizers, 7 Surfactant & Foaming Agents, 5 Rheology Modifiers, 5 Coating Systems & Additives, 4 Taste Masking, 4 Chewable & Orodispersible Aids, 1 API Stability Enhancers, 1 Lubricants & Glidants

28 Fillers, Diluents & Binders
22 Thickeners and Stabilizers
21 Solubilizers
19 Topical
19 Parenteral
17 Direct Compression
15 Granulation
14 Disintegrants & Superdisintegrants
10 Emulsifying Agents
10 Co-Processed Excipients
8 Controlled & Modified Release
7 Film Formers & Plasticizers
7 Surfactant & Foaming Agents
5 Rheology Modifiers
5 Coating Systems & Additives
4 Taste Masking
4 Chewable & Orodispersible Aids
1 API Stability Enhancers
1 Lubricants & Glidants

DIGITAL CONTENT

3 Data Compilation #PharmaFlow, 144 News #PharmaBuzz

3 Data Compilation #PharmaFlow
144 News #PharmaBuzz

GLOBAL SALES INFORMATION

30 US Medicaid Prescriptions, 96 Regulatory FDF Prices, 14 Annual Reports

30 US Medicaid Prescriptions
96 Regulatory FDF Prices
14 Annual Reports

MARKET PLACE

18 APIs, 5 FDF Dossiers, 1 EXCIPIENTS

18 APIs
5 FDF Dossiers
1 EXCIPIENTS

PATENTS & EXCLUSIVITIES

162 US Patents, 11 US Exclusivities, 97 Health Canada Patents

162 US Patents
11 US Exclusivities
97 Health Canada Patents

REF. STANDARDS & IMPURITIES

4 EDQM, 8 USP, 19 Others

4 EDQM
8 USP
19 Others

$ API Ref.Price (USD/KG) : 14,798 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Name Reset all filters

11 All

01 1PARATEK PHARMS

02 10TEVA PHARM

filter Product Reset all filters

11 All

01 7FLUTICASONE PROPIONATE

02 4FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE

filter Exclusivity Expiration Date Reset all filters

11 All

01 52024-07-09

02 52025-01-09

03 12027-03-15

filter Exclusivity Code Reset all filters

11 All

01 1I-940

02 2M-61

03 2NPP

04 1NS

05 5PED

EUROAPI Fluticasone Propionate

Product Main Page

TEVA PHARM

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

FLUTICASONE PROPIONATE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

PED

Exclusivity Expiration Date

2025-01-09

Application Number

208798

Product Number

4

Exclusivity Details

01

TEVA PHARM

FLUTICASONE PROPIONATE

International Sweetener Colloquium

Not Confirmed

TEVA PHARM

Israel

International Sweetener Colloquium

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

FLUTICASONE PROPIONATE

Exclusivity Code : PED

Exclusivity Expiration Date : 2025-01-09

Application Number : 208798

Product Number : 4

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

TEVA PHARM

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

PED

Exclusivity Expiration Date

2025-01-09

Application Number

208799

Product Number

1

Exclusivity Details

02

TEVA PHARM

FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE

International Sweetener Colloquium

Not Confirmed

TEVA PHARM

Israel

International Sweetener Colloquium

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE

Exclusivity Code : PED

Exclusivity Expiration Date : 2025-01-09

Application Number : 208799

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

TEVA PHARM

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

FLUTICASONE PROPIONATE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

PED

Exclusivity Expiration Date

2025-01-09

Application Number

208798

Product Number

7

Exclusivity Details

03

TEVA PHARM

FLUTICASONE PROPIONATE

International Sweetener Colloquium

Not Confirmed

TEVA PHARM

Israel

International Sweetener Colloquium

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

FLUTICASONE PROPIONATE

Exclusivity Code : PED

Exclusivity Expiration Date : 2025-01-09

Application Number : 208798

Product Number : 7

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

TEVA PHARM

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

M-61

Exclusivity Expiration Date

2024-07-09

Application Number

208799

Product Number

4

Exclusivity Details

04

TEVA PHARM

FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE

International Sweetener Colloquium

Not Confirmed

TEVA PHARM

Israel

International Sweetener Colloquium

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE

Exclusivity Code : M-61

Exclusivity Expiration Date : 2024-07-09

Application Number : 208799

Product Number : 4

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

TEVA PHARM

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

M-61

Exclusivity Expiration Date

2024-07-09

Application Number

208799

Product Number

1

Exclusivity Details

05

TEVA PHARM

FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE

International Sweetener Colloquium

Not Confirmed

TEVA PHARM

Israel

International Sweetener Colloquium

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE

Exclusivity Code : M-61

Exclusivity Expiration Date : 2024-07-09

Application Number : 208799

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

TEVA PHARM

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

FLUTICASONE PROPIONATE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

NS

Exclusivity Expiration Date

2024-07-09

Application Number

208798

Product Number

7

Exclusivity Details

06

TEVA PHARM

FLUTICASONE PROPIONATE

International Sweetener Colloquium

Not Confirmed

TEVA PHARM

Israel

International Sweetener Colloquium

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

FLUTICASONE PROPIONATE

Exclusivity Code : NS

Exclusivity Expiration Date : 2024-07-09

Application Number : 208798

Product Number : 7

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

TEVA PHARM

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

FLUTICASONE PROPIONATE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

NPP

Exclusivity Expiration Date

2024-07-09

Application Number

208798

Product Number

4

Exclusivity Details

07

TEVA PHARM

FLUTICASONE PROPIONATE

International Sweetener Colloquium

Not Confirmed

TEVA PHARM

Israel

International Sweetener Colloquium

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

FLUTICASONE PROPIONATE

Exclusivity Code : NPP

Exclusivity Expiration Date : 2024-07-09

Application Number : 208798

Product Number : 4

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

PARATEK PHARMS

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

FLUTICASONE PROPIONATE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

I-940

Exclusivity Expiration Date

2027-03-15

Application Number

209022

Product Number

1

Exclusivity Details

08

PARATEK PHARMS

FLUTICASONE PROPIONATE

International Sweetener Colloquium

Not Confirmed

PARATEK PHARMS

U.S.A

International Sweetener Colloquium

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

FLUTICASONE PROPIONATE

Exclusivity Code : I-940

Exclusivity Expiration Date : 2027-03-15

Application Number : 209022

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

TEVA PHARM

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

FLUTICASONE PROPIONATE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

NPP

Exclusivity Expiration Date

2024-07-09

Application Number

208798

Product Number

1

Exclusivity Details

09

TEVA PHARM

FLUTICASONE PROPIONATE

International Sweetener Colloquium

Not Confirmed

TEVA PHARM

Israel

International Sweetener Colloquium

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

FLUTICASONE PROPIONATE

Exclusivity Code : NPP

Exclusivity Expiration Date : 2024-07-09

Application Number : 208798

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

TEVA PHARM

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

PED

Exclusivity Expiration Date

2025-01-09

Application Number

208799

Product Number

4

Exclusivity Details

10

TEVA PHARM

FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE

International Sweetener Colloquium

Not Confirmed

TEVA PHARM

Israel

International Sweetener Colloquium

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE

Exclusivity Code : PED

Exclusivity Expiration Date : 2025-01-09

Application Number : 208799

Product Number : 4

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

1
2

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.